New hope for tiny lungs: simpler breathing treatment tested for premature babies in africa

NCT ID NCT06554522

Recruiting now Disease control Sponsor: Indiana University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests if giving surfactant (a natural substance that helps lungs stay open) through a less invasive method helps premature babies with breathing problems survive. About 1,500 babies weighing 1.5 to 4.4 pounds will receive this treatment in African hospitals that lack breathing machines. Researchers will track survival and complications to see if this simpler approach works better than standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREMATURE BIRTH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

newborn respiratory distress syndrome Premature Birth Pulmonary Atelectasis respiratory distress syndrome in premature infants

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREMATURE BIRTH RDS OF PREMATURITY RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANT SURFACTANT DEFICIENCY SYNDROME NEONATAL

Contacts and locations

Locations

Centre Hospitalier Universitaire Communautaire
NOT_YET_RECRUITING

Bangui, Central African Republic
Coast General Teaching & Referral Hospital
NOT_YET_RECRUITING

Mombasa, Kenya
Federal Teaching Hospital Ido-Ekiti
RECRUITING

Ido-Ekiti, Ekiti State, Nigeria
Komfo Anokye Teaching Hospital
NOT_YET_RECRUITING

Kumasi, Ghana
Korle-Bu Teaching Hospital
NOT_YET_RECRUITING

Accra, Ghana
Mama Lucy Kibaki Hospital
NOT_YET_RECRUITING

Nairobi, Kenya
Tamale Teaching Hospital
NOT_YET_RECRUITING

Tamale, Ghana
University of Ilorin Teaching Hospital
RECRUITING

Ilorin, Kwara State, Nigeria

More trials for these conditions

Other studies related to the condition(s) this trial covers.